Feb 21, 2006

RICHMOND, BC – bioLytical™ Laboratories announced today that they will start the application for Pre-market Approval (PMA) for Class III medical device with the U.S. Food and Drug Administration (FDA) for the INSTI™ kit, a HIV Rapid Antibody test. The bioLytical™ team has a meeting with the Center for Biologics Evaluation and Research (CBER), the FDA branch responsible for reviewing their application on March 31, 2006. We are hoping to have our application in by the end of 2nd quarter 2006.

bioLytical™ Laboratories (Inc.) is a leading developer and manufacturer of diagnostic tests for global health care markets. The company produces the highly accurate and reliable INSTI™ kit; the only rapid HIV test kit approved by Health Canada for use in a point of care setting, such as a doctor's office or hospital. bioLytical™ is a privately owned company with headquarters and manufacturing facility located in Richmond, British Columbia. For more information about bioLytical and INSTI™, please visit www.biolytical.com.

-30-

Media Contact:
Debbie Collins
bioLytical™ Laboratories
Telephone: (604) 204-6784 ext. 236
Cell: 604 716-7934
Toll Free: 1-866-674-6784
Email: dcollins@biolytical.com

Back